- Home
- PLUR vs XBP Comparison
PLUR vs XBP Comparison
Compare PLUR & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLUR | XBP |
|---|---|---|
| Founded | 2001 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5M | 41.3M |
| IPO Year | 2001 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLUR | XBP |
|---|---|---|
| Price | $0.96 | $3.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.3K | ★ 21.5K |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.46 | ★ 183.67 |
| EPS | ★ N/A | N/A |
| Revenue | $1,016,000.00 | ★ $872,690,000.00 |
| Revenue This Year | $902.46 | $2.47 |
| Revenue Next Year | N/A | $10.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.90 | $0.41 |
| 52 Week High | $4.87 | $8.55 |
Technical Indicators
Market Signals| Indicator | PLUR | XBP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 56.60 |
| Support Level | N/A | $2.10 |
| Resistance Level | N/A | $3.87 |
| Average True Range (ATR) | 0.00 | 0.25 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 44.70 |
Price Performance
Historical ComparisonAbout PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.